🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🧵Obesity, metrics of central adiposity, and prognostic significance in #HFpEF #HFmrEF 📌New insights on #Obesity & #HeartFailure A recent analysis from the PARAGON-HF trial shows that not all fat is equal when it comes to prognosis in HFpEF & HFmrEF. Let’s break down the

Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Urinary albumin-to-creatinine ratio an attractive, unifying biomarker of CV, kidney, and metabolic conditions may be useful for identifying and monitoring trajectory ahajournals.org/doi/10.1161/CI…

🧵🏥🏡HF Clinic that WORKS 💊❤️ New data shows a specialized Guideline-Directed Medical Therapy (GDMT) clinic significantly improves #HF outcomes Let’s unpack this impactful study step by step. 👇 #CardioTwitter #HeartFailure #MedTwitter 👉What’s the problem? 🫀 Most

Clinical staging to guide management of metabolic disorders and their sequelae: European Atherosclerosis Society statement European Society of Cardiology Journals 1️⃣ insulin resistance/pre-diabetes alone or overweight/dysfunctional adiposity + 1 one the following: liver steatosis, hypertension, or atherogenic dyslipidaemia

#obesity in pts with #heartfailure: a common challenge and a therapeutic target in HFpEF. Do not miss our #ESC_HFA Scientific Statement on the topic! onlinelibrary.wiley.com/doi/10.1002/ej… EJHF Editor-in-Chief HFAPresident Henry Han Antonio Cannata' Marco Metra Mark Petrie European Society of Cardiology European Society of Cardiology Journals

🔴Effects of finerenone on natriuretic peptide levels in heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trial #HeartFailure2025 💡 The FINEARTS-HF trial shows that finerenone significantly ⬇️NT-proBNP and clinical events in patients with

DAPA-HF & EMPEROR-Reduced trials reveal significant absolute risk reductions in cardiovascular, renal, & mortality outcomes with dapagliflozin and empagliflozin. SGLT2 inhibitors continue to redefine heart failure and CKD management. tandfonline.com/doi/full/10.10…

We report the 🎂Five years of a self-sustaining 🫀heart transplant program in the 🇮🇨Canary Islands - JHLT Open: jhltopen.org/article/S2950-…. A huge benefit for our society. unICa Doctor Negrin SoCanCar Asociación Insuficiencia Cardiaca Sanidad Gobcan Organización Nacional de Trasplantes 🙏Thanks to all the donors and their families.

🗞️ Insights into the European #heartfailure epidemiology European Society of Cardiology Journals Giuseppe Galati Amr Abdin Henry Han bit.ly/44665SJ

To delay progression of diabetic kidney disease, guidelines recommend 3 drug classes for selected patients: renin–angiotensin system inhibitors, SGLT-2 inhibitors, and finerenone. A new study provides data on simultaneous use of all 3. jwat.ch/4mW2k9O NEJM #diabetes

🔥 ¡Salas llenas, debates intensos y ciencia en cada rincón! La reunión anual #ICSEC2025 está en plena ebullición en Zaragoza. 💥 De la prevención a la terapia avanzada, pasando por cateterismos, trasplante, inteligencia artificial, cardiooncología o cuidados paliativos... ¡la

#ICSEC2025 Excelente actualización de Carles Díez del Hospital Universitari Bellvitge | HUB sobre los fármacos que han revolucionado el tratamiento de la miocardiopatia hipertrófica

Fantásticos resultados del programa de asistencia circulatoria de destino en España. Gracias Manuel Gómez Bueno por el análisis. ENHORABUENA a todos los grupos, y especialmente a los centros sin TX!. Aquel temor a empeorar los resultados parece que solo era un fantasma! Asociación Insuficiencia Cardiaca

How obesity, inflammation & systems cardiology are reshaping our role as cardiovascular clinicians. 🔬❤️ Based on @eurheartj article by Prof. Thomas Lüscher 👇 1/ Modern cardiology evolved into hyper-specialization: But what about our generalist roots? The rise of complex

Excelente #cardioPODCAST en el que se repasa el estado actual del tratamiento de la ICFEr. Julio Domingo Pascual-Figal Pedro Caravaca Pérez Antoni Bayés de Luna omny.fm/shows/cardiopo…

Refining the link between obesity and heart failure: GLP-1 receptor agonist trials and studies adopting direct adiposity measures recent GLP-1 RA trials suggest intentional weight loss positively influences outcomes in overweight/obese patients with HF cardiab.biomedcentral.com/articles/10.11…

Obesity Phenotypes Causally Affect Cardiac MRI Structure and Induced Non-ischaemic Cardiomyopathy There is a robust causal association between obesity and NICM, and with abnormalities in myocardial structure and function. HTN emerges as a pivotal mediator in the obesity–NICM

Top3 heart failure trials in June 2025 🥇ACC Scientific statement on the management of obesity in HF JACC Journals 🥈Right heart catheterization in HF European Society of Cardiology Journals 🥉AI ➡️ Enabled analysis of thermography to diagnose ADHF JACC Journals

In press 🔥🔥 Hypokalemia During Decongestion With Loop Diuretics and Hydrochlorothiazide, a Post Hoc Analysis of the CLOROTIC Trial | Circulation: Heart Failure ahajournals.org/doi/10.1161/CI…

⚠️ Acute right ventricular failure: pathophysiology, aetiology, assessment, and management‼️ 📍 State of the Art Review in European Society of Cardiology Journals Soc Esp Cardiología Asociación Insuficiencia Cardiaca Asociación CI y Cuidados Agudos Cardiovasculares SACardiología academic.oup.com/eurheartj/arti…